Treatment of Chronic Kidney Disease with Extracellular Vesicles from Mesenchymal Stem Cells and CD133<sup>+</sup> Expanded Cells: A Comparative Preclinical Analysis.

Int J Mol Sci · 2022 · PMC8910174 · PMID 35269664

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Although there were no significant differences for the biomarker albumin ( p = 0.061), a decreasing trend in this serum marker was observed ( Table 1 ). 2.4.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.